by Kall Kwik WGC | Nov 28, 2015 | Free Library
November, 2015 SMM-134 Acting at Random Life sciences companies stumble through evolutionary space and often fail.
by Kall Kwik WGC | Nov 28, 2015 | Free Library
October, 2015 SMM-133 Tragedy of the Commons Why evolution suggests that we need to be altrustic to our rivals.
by Kall Kwik WGC | Nov 3, 2015 | Free Library
September, 2015 SMM-132 Dead Man’s Shoes As the industry evolves, this article examines how obsolete business models make space for new ones.
by Kall Kwik WGC | Aug 11, 2015 | Free Library
August, 2015 SMM-130 Unintended Consequences Recent and continuing issues that the pharmaceutical industry has with business ethics remind us that good intentions can have unintended consequences. This article looks at how life science companies...
by Kall Kwik WGC | Jun 25, 2015 | Free Library
June, 2015 SMM-128 The Lasting Advantage A transforming market quickly renders existing assets and capabilities obsolete. In a life sciences market where technology, customers and competitors are evolving, organisational learning is the only...
by Kall Kwik WGC | Jun 25, 2015 | Free Library
June, 2015 SMM-129 Research Watch This Research Watch covers everything from personalised medicine, to new market entry, to alliances and networks.
